ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 — West Palm Beach, Florida

ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 is a clinical research site located in West Palm Beach, Florida, United States 33407.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 has participated in 1 clinical trials.

Therapeutic areas: Migraine Headache.

Sponsors: Impel Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in West Palm Beach

Browse all research sites in Florida · View every site in West Palm Beach

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200?

ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 conducted?

ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 has 1 clinical trials on record. Their work covers Migraine Headache.

Is ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 accredited by Crixeo Clinical Trials?

ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ENT Associates of South Florida, 4631 North Congress Avenue, Suite 200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.